The Centers for Medicare and Medicaid Services (CMS) Innovation Center has earmarked a $3 million federal grant to address opioid use disorder among pregnant and postpartum women in West Virginia.
Officials said the West Virginia Department of Health and Human Resources (DHHR) would administer the funds supporting the Maternal Opioid Model (MOM) initiative, which focuses on improving health outcomes for mothers and babies by addressing the fragmentation of care for pregnant and postpartum women receiving Medicaid benefits.
“We are grateful for the opportunity to take this successful and innovative project to the next level to ensure comprehensive services are available to all pregnant and postpartum women in West Virginia,” Christina Mullins, commissioner of DHHR’s Bureau for Behavioral Health, said.
The scope of work involves Marshall Health / Marshall University Resource Corporation leading the MOM project as the designated Care Delivery Partner for Medicaid while the West Virginia Perinatal Partnership will collaborate on the project to implement provider outreach education and support to program sites.
“Under the MOM initiative, we will explore the development of a health home model for this vulnerable population,” Cynthia Beane, commissioner of DHHR’s Bureau for Medical Services, said. “This would enable Medicaid to support services provided in care settings where behavioral health and care coordination historically have not been reimbursed.”
Through the MOM program, women are screened for substance use disorder and provided comprehensive care coordination to help ensure the best possible health outcomes.